Endpoint definition
↥321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
389
Check minimum number of events None
389
Include endpoints None
389
Extra metadata
R18_OTHER_ABNORMAL_IMMUNOL_FINDI_SERUM
No definition available.
321302 individuals
Apply sex-specific rule None
321302
Check conditions None
321302
Check pre-conditions, main-only, mode, ICD version
389
Check minimum number of events None
389
Include endpoints None
389
Extra metadata
List of similar endpoints to
Other abnormal immunological findings in serum
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 378 | 267 | 111 |
| Unadjusted prevalence (%) | 0.12 | 0.15 | 0.08 |
| Mean age at first event (years) | 43.92 | 41.94 | 48.69 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | 0.01 | 0.74 [0.19, 2.97] | 6.7e-1 | 12 |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: R18_OTHER_ABNORMAL_IMMUNOL_FINDI_SERUM – Other abnormal immunological findings in serum
GWS hits: 1
before Other abnormal immunological findings in serum
after Other abnormal immunological findings in serum
Loading survival analyses plot
Loading survival analyses table